Skip Ribbon Commands
Skip to main content
 


Pulmonary Nodule Biomarker Trial


Trial Focus

Lung Cancer

Objective

         The Biomarkers for Diagnosis of Lung Nodules Study is a prospective study of a cohort of 600 individuals with lung nodules of indeterminate etiology that are identified by CT scans. Either biopsy or repeat CT scans must be clinically indicated to determi

IRB Protocol #

09-1106

Trial Status

OPEN

Principle Investigator

YORK MILLER

Sponsor

NCI

Contact

ERIN HIRSCH at -- or --

Location

University of Colorado Hospital VA University University of Colorado Hospital VA University

Eligibility and Other Participant Information


What To Expect : This is not a treatment trial. // Eligibility criteria : Main Inclusion Criteria: 1.Adult 18-85 years of age. 2.Patients referred to pulmonologists, oncologists, or thoracic surgeons for the evaluation of peripheral lung nodules found on CT scan. 3.Repeat CT scans, biopsy or surgical excision are clinically indicated to determine the etiology of the nodule. 4.One or more lung nodules must be between 5 mm and 50 mm in the greatest diameter. 5.Patients must be fully informed of the investigational nature of the procedure and sign an informed consent. Eligibility criteria : Main Inclusion Criteria: 1.Adult 18-85 years of age. 2.Patients referred to pulmonologists, oncologists, or thoracic surgeons for the evaluation of peripheral lung nodules found on CT scan. 3.Repeat CT scans, biopsy or surgical excision are clinically indicated to determine the etiology of the nodule. 4.One or more lung nodules must be between 5 mm and 50 mm in the greatest diameter. 5.Patients must be fully informed of the investigational nature of the procedure and sign an informed consent.